Journal
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Volume 7, Issue 4, Pages 420-427Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.nano.2011.01.002
Keywords
Cancer therapy; Core-shell; Gold-coated iron; Nanoparticles
Funding
- National Science Council, of Taiwan [NSC-98-3114-M-006-002, 98-2218-E-006-008-MY3]
- Australian Research Council (ARC) [LE0775598]
- University of Sydney
- Australian Research Council [LE0775598] Funding Source: Australian Research Council
Ask authors/readers for more resources
Gold-coated iron nanoparticles (NPs) selectively and significantly (P <0.0001) inhibit proliferation of oral-and colorectal-cancer cells in vitro at doses as low as 5 mu g/mL, but have little adverse effect on normal healthy control cells. The particle treatment caused delay in cell-cycle progression, especially in the S-phase. There was no significant difference in the NP uptake between cancer and control cells, and cytotoxicity resulted primarily from the iron core, before oxidation, rather than from the Fe ions released from the core. In contrast with magnetic NPs that usually serve as drug carriers, diagnostic probes or hyperthermia media, the iron, before oxidation, in the NPs selectively suppressed cancer cell growth and left healthy control cells unaffected in vitro and in vivo. This novel nanomaterial holds great promise as a therapeutic tool in nanomedicine. From the Clinical Editor: Gold-coated iron nanoparticles (NPs) selectively suppressed squamous cell carcinoma (SCC) and colorectal cancer (CRC) cell growth, but left healthy control cells unaffected both in vitro and in vivo. The particles were equally uptaken by all cells, but delayed cell progression only for cancer cells. The origin is related to the iron core: neither iron ions nor the oxidized NPs have the same outcome. (C) 2011 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available